Liquidia Corporation remains a Buy for risk-tolerant biotech investors, supported by strong Yutrepia launch metrics and ...

An obsession with the numbers can sink your strategy. by Michael Harris and Bill Tayler Tying performance metrics to strategy has become an accepted best practice over the past few decades. Strategy ...

Michael is a former senior editor of investing and trading products for Investopedia. He has 20+ years of mutual fund, macro market research, institutional trading desk, and trading education ...

Sarah Hudgens is a content pro with over 15 years of experience writing and editing copy for a wide range of industry verticals and channels. Distraction and mindfulness are common strategies to cope ...